Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction | MicrobiomeTrials← Back to trialsNCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-09-02Est. Completion: 2026-09-30
Enrollment target: 40 participants Other microbiome trials you might be interested in
Functional DyspepsiaSmall Intestinal Bacterial Overgrowth
The purpose of this study is to investigate the prevalence of small intestinal bacterial overgrowth (SIBO) in patients w…
Indianapolis, United StatesCompleted Dec 2026
Eosinophilic EsophagitisGastroesophageal Reflux Disease (GERD)GastroparesisFunctional VomitingIrritable Bowel Syndrome (IBS)ConstipationChronic Intestinal Pseudo-obstructionFecal IncontinenceSmall Intestinal Bacterial Overgrowth
Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to …
Indianapolis, United StatesEst. completion Nov 2026
Autoimmune Hepatitis
Pediatric autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH) and overlap syndromes like sclerosing …
New Delhi, IndiaEst. completion Apr 30, 2028